BARD1 and breast cancer: To overcome the abovementioned limitations, we took advantage of a deleterious nonsense mutation, namely, c.1690C>T (p.Q564X), identified in the Polish population in several independent studies [36,37,76], to provide a reliable estimation of BC risk associated with BARD1 mutations.